(Q45938307)

18 December 2017

title

RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer. (English)

1 reference

18 December 2017

author

Achim Treumann

8

1 reference

18 December 2017

Leonie S. Young

12

1 reference

18 December 2017

Jean McBryan

Jean McBryan

3

0 references

Marie McIlroy

Marie McIlroy

10

0 references

Aisling M Redmond

2

Aisling Redmond

1 reference

18 December 2017

Sinéad Cocchiglia

4

Sinead Cocchiglia

1 reference

18 December 2017

author name string

Padraic Flavin

1

1 reference

18 December 2017

Paul Tibbitts

5

1 reference

18 December 2017

Patrick Fahy-Browne

6

1 reference

18 December 2017

Elaine Kay

7

1 reference

18 December 2017

Kilian Perrem

9

1 reference

18 December 2017

Arnold D K Hill

11

1 reference

18 December 2017

language of work or name

English

0 references

publication date

13 July 2011

1 reference

18 December 2017

published in

FEBS Letters

1 reference

18 December 2017

volume

585

1 reference

18 December 2017

issue

15

1 reference

18 December 2017

page(s)

2537-2544

1 reference

18 December 2017

Telomere length, stem cells and aging

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Protein composition of catalytically active human telomerase from immortal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Regulation of telomerase by telomeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

p53-dependent down-regulation of telomerase is mediated by p21waf1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

BRCA1 Inhibition of Telomerase Activity in Cultured Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Direct activation of TERT transcription by c-MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Telomere uncapping and alternative lengthening of telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

RVB1/RVB2: running rings around molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Novel genes associated with malignant melanoma but not benign melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.07.005

10.1016/J.FEBSLET.2011.07.005

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017